Search research articles
Contact Us
Filters
Showing results (211-220 of 353) with videos related to
Page
of 36
Sort By:
European Journal of Ophthalmology
|
August 31, 2021
Association analysis of variants rs35934224 in <i>TXNRD2</i> and rs6478746 in <i>LMX1B</i> in primary angle-closure and pseudoexfoliation glaucoma
Altaf A Kondkar, Tahira Sultan, Abdullah S Alobaidan, et al.
BMC Research Notes
|
December 1, 2017
Polymorphism rs13334190 in zinc finger protein 469 (ZNF469) is not a risk factor for keratoconus in a Saudi cohort
Hatem Kalantan, Altaf A Kondkar, Tahira Sultan, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion
Matthew A Sparks, Johannes Stegbauer, Daian Chen, et al.
Frontiers in Nutrition
|
April 25, 2022
Development of Protein Rich Pregelatinized Whole Grain Cereal Bar Enriched With Nontraditional Ingredient: Nutritional, Phytochemical, Textural, and Sensory Characterization
Farhana Mehraj Allai, B N Dar, Khalid Gul, et al.
Journal of Translational Medicine
|
January 15, 2016
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial
Raya Leibowitz-Amit, Melania Pintilie, Leila Khoja, et al.
Genetic Testing and Molecular Biomarkers
|
December 1, 2017
Polymorphism rs10483727 in the SIX1/SIX6 Gene Locus Is a Risk Factor for Primary Open Angle Glaucoma in a Saudi Cohort
Altaf A Kondkar, Taif A Azad, Faisal A Almobarak, et al.
Investigational New Drugs
|
March 28, 2014
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer
Arun A Azad, Emma K Beardsley, Sebastian J Hotte, et al.
European Urology
|
March 12, 2025
T-cell Engagers in Prostate Cancer
Chadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
Genetic Testing and Molecular Biomarkers
|
August 20, 2016
Analysis of Cyclin-Dependent Kinase Inhibitor-2B rs1063192 Polymorphism in Saudi Patients with Primary Open-Angle Glaucoma
Khaled K Abu-Amero, Altaf A Kondkar, Ahmed Mousa, et al.
Future Oncology (London, England)
|
October 25, 2024
The TALAPRO-3 study design: a plain language summary
Neeraj Agarwal, Fred Saad, Arun A Azad, et al.
Page
of 36
Search research articles
Search
Showing results (211-220 of 353) with videos related to
Sort By:
Page
of 36
European Journal of Ophthalmology
|
August 31, 2021
Association analysis of variants rs35934224 in <i>TXNRD2</i> and rs6478746 in <i>LMX1B</i> in primary angle-closure and pseudoexfoliation glaucoma
Altaf A Kondkar, Tahira Sultan, Abdullah S Alobaidan, et al.
BMC Research Notes
|
December 1, 2017
Polymorphism rs13334190 in zinc finger protein 469 (ZNF469) is not a risk factor for keratoconus in a Saudi cohort
Hatem Kalantan, Altaf A Kondkar, Tahira Sultan, et al.
Journal of the American Society of Nephrology : JASN
|
April 10, 2015
Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion
Matthew A Sparks, Johannes Stegbauer, Daian Chen, et al.
Frontiers in Nutrition
|
April 25, 2022
Development of Protein Rich Pregelatinized Whole Grain Cereal Bar Enriched With Nontraditional Ingredient: Nutritional, Phytochemical, Textural, and Sensory Characterization
Farhana Mehraj Allai, B N Dar, Khalid Gul, et al.
Journal of Translational Medicine
|
January 15, 2016
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial
Raya Leibowitz-Amit, Melania Pintilie, Leila Khoja, et al.
Genetic Testing and Molecular Biomarkers
|
December 1, 2017
Polymorphism rs10483727 in the SIX1/SIX6 Gene Locus Is a Risk Factor for Primary Open Angle Glaucoma in a Saudi Cohort
Altaf A Kondkar, Taif A Azad, Faisal A Almobarak, et al.
Investigational New Drugs
|
March 28, 2014
A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer
Arun A Azad, Emma K Beardsley, Sebastian J Hotte, et al.
European Urology
|
March 12, 2025
T-cell Engagers in Prostate Cancer
Chadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
Genetic Testing and Molecular Biomarkers
|
August 20, 2016
Analysis of Cyclin-Dependent Kinase Inhibitor-2B rs1063192 Polymorphism in Saudi Patients with Primary Open-Angle Glaucoma
Khaled K Abu-Amero, Altaf A Kondkar, Ahmed Mousa, et al.
Future Oncology (London, England)
|
October 25, 2024
The TALAPRO-3 study design: a plain language summary
Neeraj Agarwal, Fred Saad, Arun A Azad, et al.
Page
of 36